Abstract:Abstract Glycosaminoglycans are extended linear polysaccharides present on cell surfaces and within the extracellular matrix that play crucial roles in various biological processes. Two prominent glycosaminoglycans, heparan sulfate and chondroitin sulfate, are covalently linked to proteoglycan core proteins through a common tetrasaccharide linker comprising glucuronic acid, galactose, galactose, and xylose moities. This tetrasaccharide linker is meticulously assembled step by step by four Golgi-localized glycosyltransferases. The addition of the fifth sugar moiety, either N-acetylglucosamine or N-acetylgalactosamine, initiates further chain elongation, resulting in the formation of heparan sulfate or chondroitin sulfate, respectively. Despite the fundamental significance of this step in glycosaminoglycan biosynthesis, its regulatory mechanisms have remained elusive. In this study, we detail the expression and purification of the four linker-synthesizing glycosyltransferases and their utilization in the production of fluorescent peptides carrying the native tetrasaccharide linker. We generated five tetrasaccharide peptides, mimicking the core proteins of either heparan sulfate or chondroitin sulfate proteoglycans. These peptides were readily accepted as substrates by the EXTL3 enzyme, which adds an N-acetylglucosamine moiety, thereby initiating heparan sulfate biosynthesis. Importantly, EXTL3 showed a preference towards peptides mimicking the core proteins of heparan sulfate proteoglycans over the ones from chondroitin sulfate proteoglycans. This suggests that EXTL3 could play a role in the decision-making step during glycosaminoglycan biosynthesis. The innovative strategy for chemo-enzymatic synthesis of fluorescent-labeled linker-peptides promises to be instrumental in advancing future investigations into the initial steps and the divergent step of glycosaminoglycan biosynthesis.

Chemoenzymatic synthesis of sulfur-linked sugar polymers as heparanase inhibitors

Design Principle of Heparanase Inhibitors: A Combined In Vitro and In Silico Study

Facile Preparation of Cancer-Specific Polyelectrolyte Nanogels from Natural and Synthetic Sugar Polymers

Chemical O-sulfation of N-sulfoheparosan: a Route to Rare N-sulfo-3-O-sulfoglucosamine and 2-O-sulfoglucuronic Acid.

Synthesis of Novel Glycolipid Mimetics of Heparan Sulfate and Their Application in Colorectal Cancer Treatment in a Mouse Model

A Universal and Modular Scaffold for Heparanase Activatable Probes and Drugs

Abstract 3105: Design principle of heparanase inhibitors: A combined in vitro and in silico study

Interacting polymer-modification enzymes in heparan sulfate biosynthesis

Structural analysis of synthetic heparan sulfate oligosaccharides with fibroblast growth factors and heparin-binding hemagglutinin

Nanopore-regulated in situ polymerization for synthesis of homogeneous heparan sulfate with low dispersity

Bioactive synthetic heparan sulfate and heparin derivatives: From long fragments mimetics to chimeras

Chemo-enzymatic synthesis of tetrasaccharide linker peptides to study the divergent step in glycosaminoglycan biosynthesis

Investigation of the biological functions of heparan sulfate using a chemoenzymatic synthetic approach

Total synthesis of a sialyl Lewis(x) derivative for the diagnosis of cancer.

Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase

Investigation of inhibitory effect of sulfated chitosan oligomer on human heparanase enzyme: in silico and in vitro studies

Chemoenzymatic Synthesis of Sulfated N-Glycans Recognized by Siglecs and Other Glycan-Binding Proteins

Synthesis of alkyne- and azide-functionalised aziridine and epoxide carbocycles for development of selective glucuronidase mechanism-based inhibitors

Chemoenzymatic Synthesis of Homogeneous Chondroitin Polymers and Its Derivatives.

Enabling Chemoenzymatic Strategies and Enzymes for Synthesizing Sialyl Glycans and Sialyl Glycoconjugates

Solid‐Phase‐Supported Chemoenzymatic Synthesis and Analysis of Chondroitin Sulfate Proteoglycan Glycopeptides